Next Article in Journal
An Important Factor—Impact
Previous Article in Journal
The First Results of Extended Newborn Screening in Slovakia—Differences between the Majority and the Roma Ethnic Group
Open AccessCase Report

Phenylketonuria and Hirschsprung Disease—A Report of an Unusual Neonatal Presentation

1
University Children’s Hospital, Basel 4056, Switzerland
2
Swiss Newborn Screening Laboratory, and Children’s Research Center, University Children’s Hospital, Zurich 8032, Switzerland
3
Division of Metabolism, and Children’s Research Center, University Children’s Hospital, Zurich 8032, Switzerland
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Neonatal Screen. 2017, 3(3), 24; https://doi.org/10.3390/ijns3030024
Received: 25 July 2017 / Revised: 25 August 2017 / Accepted: 25 August 2017 / Published: 30 August 2017
We describe a term born boy of non-consanguineous Swiss parents with tetrahydrobiopterine (BH4)-responsive Phenylketonuria (PKU) and Hirschsprung disease with unusual neonatal presentation. The child presented with floppiness, irritability, recurrent bilious vomiting and failure to pass meconium until 32 hours after birth, resulting in the clinical suspicion of an intoxication-type metabolic disease such as maple syrup urine disease (MSUD). Although the slightly elevated branched-chain amino acids in newborn screening on the fourth day of life initially supported the clinical suspicion of MSUD, the elevated Phenylalanine (Phe) of 650 µmol/L, low Tyrosine (Tyr) of 30 µmol/L, and a Phe/Tyr ratio of 22, led to the diagnosis of PKU. BH4-testing resulted in a significant decrease of Phe from 1011 to 437 µmol/L within 24 h. Urinary pterins and dihydropteridine reductase (DHPR) activity were normal, supporting the diagnosis of BH4-responsive PKU. Dietary restriction of Phe was initiated immediately, but oral feeding turned out to be difficult because of gastrointestinal symptoms. Intestinal motility disorder was suspected due to distended abdomen, obstructive symptoms and radiological findings with dilated intestinal loops and lack of intestinal gas in the anorectal region. Hirschsprung disease was confirmed by rectal suction biopsies and treated by a laparoscopically-assisted transanal pull-through (de la Torre) procedure. The boy is additionally compound heterozygous for two mutations in the phenylalanine hydroxylase (PAH) gene, which confirmed BH4-responsive PKU. It is the first case to be described in the literature of the comorbidity of PKU and Hirschsprung disease. View Full-Text
Keywords: Phenylketonuria; maple syrup urine disease; Hirschsprung disease; intestinal motility disorder Phenylketonuria; maple syrup urine disease; Hirschsprung disease; intestinal motility disorder
MDPI and ACS Style

Lenherr, N.; Pfeifle, V.A.; Holland-Cunz, S.; Sluka, S.H.M.; Thöny, B.; Szinnai, G.; Huemer, M.; Rohrbach, M.; Fingerhut, R. Phenylketonuria and Hirschsprung Disease—A Report of an Unusual Neonatal Presentation. Int. J. Neonatal Screen. 2017, 3, 24.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop